---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-020400"
form_type: "8-K/A"
ticker: "AIXN"
cik: "0000835662"
company_name: "AiXin Life International, Inc."
filed_at: "2021-08-17T23:59:59+00:00"
generated_at: "2026-06-29T09:43:16.929584+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Aixin Life files financial statements for acquired pharmacies; shows 2020 net loss of $185K

## Summary
- Acquired entity Chengdu Aixintang Pharmacy (9 pharmacies) had 2020 revenue of $1.26M and net loss of $185K.
- Accumulated deficit at Dec 2020 was $1.19M; stockholders' deficit of $987K.
- Pro forma financials also include hotel entity from a separate May 2021 acquisition.
- Amendment corrects prior 8-K which misstated the acquired entity's name.
- Audited and unaudited combined financials now filed for years ended 2020/2019 and Q1 2021.

## SEC filing metadata
- accession: 0001493152-21-020400
- form_type: 8-K/A
- ticker: AIXN
- cik: 0000835662
- company_name: AiXin Life International, Inc.
- filed_at: 2021-08-17T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/835662/000149315221020400/0001493152-21-020400-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/835662/000149315221020400/form-8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-020400
- JSON: https://secwatch.observer/filing/0001493152-21-020400.json
- Plain text: https://secwatch.observer/filing/0001493152-21-020400.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.